Real‐world experience with venetoclax and hypomethylating agents in myelodysplastic syndromes with excess blasts
Year: 2022
Type: article
Study design: Observational Study
Source: American Journal of Hematology
DOI: 10.1002/ajh.26539
Authors: Naseema Gangat, Kristen McCullough, Isla Johnson, Aref Al‐Kali, Kebede H. Begna, Mrinal M. Patnaik, Mark R. Litzow, William Hogan, Mithun Shah, Hassan Alkhateeb, Abhishek Mangaonkar, James M. Foran, Talha Badar, Jeanne M. Palmer, Lisa Sproat, Cecilia Y. Arana Yi, Animesh Pardanani, Ayalew Tefferi
Institutions: Mayo Clinic, Mayo Clinic in Florida, Mayo Clinic in Arizona
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: AbbVie
OpenAlex ID: W4220843665